In 2020, when COVID-19 was making headlines globally, a company that specialized in producing organoids — tiny, lab-grown organ analogues — of respiratory tissue was launched in Japan. A practicing ...

Add Yahoo as a preferred source to see more of our stories on Google. Scientists in China have reported transplanting a genetically modified pig lung into a human. The 39-year-old patient was a brain ...

Researchers have shown that the IGFBP3 protein plays a relevant role in human lung development. The results of the study, which used organoids derived from embryonic lungs, open up new perspectives on ...

Red blood cells carry oxygen from the lungs to every other organ, and blood-forming stem cells must make about 200 billion new red blood cells each day to keep the oxygen flowing. For many years, ...

A new research paper was published in Volume 18 of Aging-US on March 3, 2026, titled "P38 MAPK is involved in epigenetic regulation of fibrotic genes in replication induced senescence in lung ...

Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. Doctors at the First ...

Researchers of the University of Barcelona and the August Pi y Sunyer Biomedical Research Institute (IDIBAPS) have shown that the IGFBP3 protein plays a relevant role in human lung development. The ...

For the first time in history, scientists in China have transplanted a lung from a genetically modified pig into a human patient. As detailed in a paper published in the journal Nature, the team of ...

MUNICH & SEATTLE--(BUSINESS WIRE)--Helmholtz Munich and Parse Biosciences today announced a strategic partnership to generate the world’s broadest lung disease perturbation atlas, powered by Parse ...

Scientists have dreamed for centuries about using animal organs to treat ailing humans. In recent years, those efforts have begun to bear fruit: Researchers have begun transplanting the hearts and ...

Helmholtz Munich and Parse Biosciences today announced a strategic partnership to generate the world’s broadest lung disease perturbation atlas, powered by Parse Biosciences’ GigaLab platform. Using a ...